Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: Renal Hypothermia During Partial Nephrectomy [NA]
This entry reports a clinical trial on renal hypothermia during partial nephrectomy, sponsored by Ottawa Hospital Research Institute; the cu…
-
CLINICAL_TRIALS research · 2016-10-05Clinical Trial Update: Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage [NA]
Clinical trial update describing robot-assisted laparoscopic radiofrequency ablation–assisted enucleation for T1a renal cell carcinoma, with…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating combinations of D-CIK immunotherapy with anti-PD-1 therapy in refractory solid tumors, including hepatoce…
-
CLINICAL_TRIALS research · 2016-07-29Clinical Trial Update: Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial Nephrectomy [NA]
This clinical trial compares transperitoneal versus retroperitoneal laparoscopic or robotic partial nephrectomy for renal cell carcinoma; cu…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: DC1s-CTL Cellular Therapy for Renal Cell Carcinoma [Phase 1, Phase 2]
This update covers a Phase 1/2 clinical trial of DC1s-CTL cellular therapy for renal cell carcinoma, with current status not disclosed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-05-03Clinical Trial Update: Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage [NA]
A clinical trial entry for zero ischemia laparoscopic radiofrequency/microwave ablation assisted enucleation of renal cell carcinoma at T1 s…
-
CLINICAL_TRIALS research · 2016-04-26Clinical Trial Update: Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC） [Phase 2]
A Phase II clinical trial comparing anlotinib versus sunitinib in patients with advanced renal cell carcinoma; the current status of the stu…
-
CLINICAL_TRIALS research · 2016-03-01Clinical Trial Update: A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma. [Phase 2]
Phase II trial investigating two Sunitinib dosing schedules as first-line therapy for metastatic renal cell carcinoma; status is unknown.
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)
A completed prospective study evaluating acute cardiovascular effects of first-line sunitinib in metastatic renal cell carcinoma, with focus…
-
CLINICAL_TRIALS research · 2016-01-05Clinical Trial Update: A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 [NA]
Expanded access protocol for SU011248 in patients with metastatic renal cell carcinoma who are ineligible for participation in other SU01124…
-
CLINICAL_TRIALS research · 2015-07-01Clinical Trial Update: DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating [Phase 2]
Phase 2 study evaluating a dendritic cell vaccine in combination with cytokine-induced killer cells for renal cancer; recruitment has not st…
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: Metabolomic Profiling in Renal Cell Carcinoma
Clinical trial update focusing on metabolomic profiling in renal cell carcinoma, sponsored by Cambridge University Hospitals NHS Foundation …
-
CLINICAL_TRIALS research · 2015-05-07Clinical Trial Update: Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma
A clinical trial evaluates whether preoperative HbA1c levels predict outcomes in renal cell carcinoma.
-
CLINICAL_TRIALS research · 2014-11-19Clinical Trial Update: IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy. [Phase 1, Phase 2]
A clinical trial investigates irreversible electroporation of kidney tumors prior to partial nephrectomy in Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2014-08-13Clinical Trial Update: Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage [NA]
Clinical trial update on a zero-ischemia laparoscopic radiofrequency ablation–assisted enucleation approach for early-stage renal cell carci…
-
CLINICAL_TRIALS research · 2014-08-04Clinical Trial Update: Molecular Determinants for Therapy Response on Renal Cell Carcinoma [NA]
This clinical trial update investigates molecular determinants of therapy response in renal cell carcinoma; current status and trial phase a…
-
CLINICAL_TRIALS research · 2014-05-14Clinical Trial Update: Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
A completed genome-wide association study aiming to identify genetic predictors of response to targeted therapy in hepatocellular carcinoma …
-
CLINICAL_TRIALS research · 2014-02-25Clinical Trial Update: SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer
SWOG-9023 provides DNA analysis of tumor tissue from patients with metastatic kidney cancer; the trial status is completed.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update evaluating bevacizumab plus interleukin-2 in metastatic renal cell carcinoma.
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib given before and after surgery in patients with stage IV kidney cancer.
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 [Phase 2]
A Phase 2 study assessing high-dose intravenous interleukin-2 in patients with metastatic renal cell carcinoma that did not respond to prior…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of interleukin-2 in patients with metastatic or recurrent renal cell carcinoma.
-
CLINICAL_TRIALS research · 2013-11-08Clinical Trial Update: A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
This clinical trial update notes that the study evaluating the urinary biomarker Kidney Injury Molecule-1 for detecting renal cell carcinoma…
-
CLINICAL_TRIALS research · 2013-09-20Clinical Trial Update: Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating interleukin-2 with or without histamine dihydrochloride for metastatic renal cell carcinoma (kidney cancer…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer [Phase 2]
This entry reports an ongoing Phase 2 clinical trial evaluating Sunitinib given before or after surgery in patients with metastatic renal ce…